Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SVF-MSC in Living-Related Kidney Transplants
NCT02492308Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 2, randomised trial in kidney transplant rejection (2 arms), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Primary endpoint: Effects of autologous SVF derived MSC transplantation on reducing the dosage of immunosuppressant at 1 year. Status: unknown.
02
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02492308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492308.